Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Biologic Drugs market report explains the definition, types, applications, major countries, and major players of the Biologic Drugs market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Sanofi
Johnson & Johnson
Merck & Co
Eli Lilly
Abbott Laboratories
Amgen
Roche
Pfizer
Novartis
Amgen
By Type:
Humira
Remicade
Rituxan
Enbrel
Lantus
Avastin
Herceptin
Others
By End-User:
Diabetes
Inflammation
Auto-Immune Diseases
Blood Diseases
Cardiovascular Diseases
Others
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Biologic Drugs Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Biologic Drugs Outlook to 2028- Original Forecasts
-
2.2 Biologic Drugs Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Biologic Drugs Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Biologic Drugs Market- Recent Developments
-
6.1 Biologic Drugs Market News and Developments
-
6.2 Biologic Drugs Market Deals Landscape
7 Biologic Drugs Raw Materials and Cost Structure Analysis
-
7.1 Biologic Drugs Key Raw Materials
-
7.2 Biologic Drugs Price Trend of Key Raw Materials
-
7.3 Biologic Drugs Key Suppliers of Raw Materials
-
7.4 Biologic Drugs Market Concentration Rate of Raw Materials
-
7.5 Biologic Drugs Cost Structure Analysis
-
7.5.1 Biologic Drugs Raw Materials Analysis
-
7.5.2 Biologic Drugs Labor Cost Analysis
-
7.5.3 Biologic Drugs Manufacturing Expenses Analysis
8 Global Biologic Drugs Import and Export Analysis (Top 10 Countries)
-
8.1 Global Biologic Drugs Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Biologic Drugs Export by Region (Top 10 Countries) (2017-2028)
9 Global Biologic Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Biologic Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Humira Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Remicade Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Rituxan Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Enbrel Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Lantus Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Avastin Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Herceptin Consumption and Growth Rate (2017-2022)
-
9.1.8 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Biologic Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Diabetes Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Inflammation Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Auto-Immune Diseases Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Blood Diseases Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Others Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Biologic Drugs Market Analysis and Outlook till 2022
-
10.1 Global Biologic Drugs Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Biologic Drugs Consumption (2017-2022)
-
10.2.2 Canada Biologic Drugs Consumption (2017-2022)
-
10.2.3 Mexico Biologic Drugs Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Biologic Drugs Consumption (2017-2022)
-
10.3.2 UK Biologic Drugs Consumption (2017-2022)
-
10.3.3 Spain Biologic Drugs Consumption (2017-2022)
-
10.3.4 Belgium Biologic Drugs Consumption (2017-2022)
-
10.3.5 France Biologic Drugs Consumption (2017-2022)
-
10.3.6 Italy Biologic Drugs Consumption (2017-2022)
-
10.3.7 Denmark Biologic Drugs Consumption (2017-2022)
-
10.3.8 Finland Biologic Drugs Consumption (2017-2022)
-
10.3.9 Norway Biologic Drugs Consumption (2017-2022)
-
10.3.10 Sweden Biologic Drugs Consumption (2017-2022)
-
10.3.11 Poland Biologic Drugs Consumption (2017-2022)
-
10.3.12 Russia Biologic Drugs Consumption (2017-2022)
-
10.3.13 Turkey Biologic Drugs Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Biologic Drugs Consumption (2017-2022)
-
10.4.2 Japan Biologic Drugs Consumption (2017-2022)
-
10.4.3 India Biologic Drugs Consumption (2017-2022)
-
10.4.4 South Korea Biologic Drugs Consumption (2017-2022)
-
10.4.5 Pakistan Biologic Drugs Consumption (2017-2022)
-
10.4.6 Bangladesh Biologic Drugs Consumption (2017-2022)
-
10.4.7 Indonesia Biologic Drugs Consumption (2017-2022)
-
10.4.8 Thailand Biologic Drugs Consumption (2017-2022)
-
10.4.9 Singapore Biologic Drugs Consumption (2017-2022)
-
10.4.10 Malaysia Biologic Drugs Consumption (2017-2022)
-
10.4.11 Philippines Biologic Drugs Consumption (2017-2022)
-
10.4.12 Vietnam Biologic Drugs Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Biologic Drugs Consumption (2017-2022)
-
10.5.2 Colombia Biologic Drugs Consumption (2017-2022)
-
10.5.3 Chile Biologic Drugs Consumption (2017-2022)
-
10.5.4 Argentina Biologic Drugs Consumption (2017-2022)
-
10.5.5 Venezuela Biologic Drugs Consumption (2017-2022)
-
10.5.6 Peru Biologic Drugs Consumption (2017-2022)
-
10.5.7 Puerto Rico Biologic Drugs Consumption (2017-2022)
-
10.5.8 Ecuador Biologic Drugs Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Biologic Drugs Consumption (2017-2022)
-
10.6.2 Kuwait Biologic Drugs Consumption (2017-2022)
-
10.6.3 Oman Biologic Drugs Consumption (2017-2022)
-
10.6.4 Qatar Biologic Drugs Consumption (2017-2022)
-
10.6.5 Saudi Arabia Biologic Drugs Consumption (2017-2022)
-
10.6.6 United Arab Emirates Biologic Drugs Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Biologic Drugs Consumption (2017-2022)
-
10.7.2 South Africa Biologic Drugs Consumption (2017-2022)
-
10.7.3 Egypt Biologic Drugs Consumption (2017-2022)
-
10.7.4 Algeria Biologic Drugs Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Biologic Drugs Consumption (2017-2022)
-
10.8.2 New Zealand Biologic Drugs Consumption (2017-2022)
11 Global Biologic Drugs Competitive Analysis
-
11.1 Sanofi
-
11.1.1 Sanofi Company Details
-
11.1.2 Sanofi Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Sanofi Biologic Drugs Main Business and Markets Served
-
11.1.4 Sanofi Biologic Drugs Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Johnson & Johnson
-
11.2.1 Johnson & Johnson Company Details
-
11.2.2 Johnson & Johnson Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Johnson & Johnson Biologic Drugs Main Business and Markets Served
-
11.2.4 Johnson & Johnson Biologic Drugs Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Merck & Co
-
11.3.1 Merck & Co Company Details
-
11.3.2 Merck & Co Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Merck & Co Biologic Drugs Main Business and Markets Served
-
11.3.4 Merck & Co Biologic Drugs Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Eli Lilly
-
11.4.1 Eli Lilly Company Details
-
11.4.2 Eli Lilly Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Eli Lilly Biologic Drugs Main Business and Markets Served
-
11.4.4 Eli Lilly Biologic Drugs Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Abbott Laboratories
-
11.5.1 Abbott Laboratories Company Details
-
11.5.2 Abbott Laboratories Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Abbott Laboratories Biologic Drugs Main Business and Markets Served
-
11.5.4 Abbott Laboratories Biologic Drugs Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Amgen
-
11.6.1 Amgen Company Details
-
11.6.2 Amgen Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Amgen Biologic Drugs Main Business and Markets Served
-
11.6.4 Amgen Biologic Drugs Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Roche
-
11.7.1 Roche Company Details
-
11.7.2 Roche Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Roche Biologic Drugs Main Business and Markets Served
-
11.7.4 Roche Biologic Drugs Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Pfizer
-
11.8.1 Pfizer Company Details
-
11.8.2 Pfizer Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Pfizer Biologic Drugs Main Business and Markets Served
-
11.8.4 Pfizer Biologic Drugs Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Novartis
-
11.9.1 Novartis Company Details
-
11.9.2 Novartis Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Novartis Biologic Drugs Main Business and Markets Served
-
11.9.4 Novartis Biologic Drugs Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Amgen
-
11.10.1 Amgen Company Details
-
11.10.2 Amgen Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Amgen Biologic Drugs Main Business and Markets Served
-
11.10.4 Amgen Biologic Drugs Product Portfolio
-
11.10.5 Recent Research and Development Strategies
12 Global Biologic Drugs Market Outlook by Types and Applications to 2028
-
12.1 Global Biologic Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Humira Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Remicade Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Rituxan Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Enbrel Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Lantus Consumption Forecast and Growth Rate (2022-2028)
-
12.1.6 Global Avastin Consumption Forecast and Growth Rate (2022-2028)
-
12.1.7 Global Herceptin Consumption Forecast and Growth Rate (2022-2028)
-
12.1.8 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Biologic Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Inflammation Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Auto-Immune Diseases Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Blood Diseases Consumption Forecast and Growth Rate (2022-2028)
-
12.2.5 Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
12.2.6 Global Others Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Biologic Drugs Market Analysis and Outlook to 2028
-
13.1 Global Biologic Drugs Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Biologic Drugs Consumption Forecast (2022-2028)
-
13.2.2 Canada Biologic Drugs Consumption Forecast (2022-2028)
-
13.2.3 Mexico Biologic Drugs Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Biologic Drugs Consumption Forecast (2022-2028)
-
13.3.2 UK Biologic Drugs Consumption Forecast (2022-2028)
-
13.3.3 Spain Biologic Drugs Consumption Forecast (2022-2028)
-
13.3.4 Belgium Biologic Drugs Consumption Forecast (2022-2028)
-
13.3.5 France Biologic Drugs Consumption Forecast (2022-2028)
-
13.3.6 Italy Biologic Drugs Consumption Forecast (2022-2028)
-
13.3.7 Denmark Biologic Drugs Consumption Forecast (2022-2028)
-
13.3.8 Finland Biologic Drugs Consumption Forecast (2022-2028)
-
13.3.9 Norway Biologic Drugs Consumption Forecast (2022-2028)
-
13.3.10 Sweden Biologic Drugs Consumption Forecast (2022-2028)
-
13.3.11 Poland Biologic Drugs Consumption Forecast (2022-2028)
-
13.3.12 Russia Biologic Drugs Consumption Forecast (2022-2028)
-
13.3.13 Turkey Biologic Drugs Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Biologic Drugs Consumption Forecast (2022-2028)
-
13.4.2 Japan Biologic Drugs Consumption Forecast (2022-2028)
-
13.4.3 India Biologic Drugs Consumption Forecast (2022-2028)
-
13.4.4 South Korea Biologic Drugs Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Biologic Drugs Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Biologic Drugs Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Biologic Drugs Consumption Forecast (2022-2028)
-
13.4.8 Thailand Biologic Drugs Consumption Forecast (2022-2028)
-
13.4.9 Singapore Biologic Drugs Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Biologic Drugs Consumption Forecast (2022-2028)
-
13.4.11 Philippines Biologic Drugs Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Biologic Drugs Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Biologic Drugs Consumption Forecast (2022-2028)
-
13.5.2 Colombia Biologic Drugs Consumption Forecast (2022-2028)
-
13.5.3 Chile Biologic Drugs Consumption Forecast (2022-2028)
-
13.5.4 Argentina Biologic Drugs Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Biologic Drugs Consumption Forecast (2022-2028)
-
13.5.6 Peru Biologic Drugs Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Biologic Drugs Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Biologic Drugs Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Biologic Drugs Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Biologic Drugs Consumption Forecast (2022-2028)
-
13.6.3 Oman Biologic Drugs Consumption Forecast (2022-2028)
-
13.6.4 Qatar Biologic Drugs Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Biologic Drugs Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Biologic Drugs Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Biologic Drugs Consumption Forecast (2022-2028)
-
13.7.2 South Africa Biologic Drugs Consumption Forecast (2022-2028)
-
13.7.3 Egypt Biologic Drugs Consumption Forecast (2022-2028)
-
13.7.4 Algeria Biologic Drugs Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Biologic Drugs Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Biologic Drugs Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Biologic Drugs
-
Figure of Biologic Drugs Picture
-
Table Global Biologic Drugs Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Biologic Drugs Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Humira Consumption and Growth Rate (2017-2022)
-
Figure Global Remicade Consumption and Growth Rate (2017-2022)
-
Figure Global Rituxan Consumption and Growth Rate (2017-2022)
-
Figure Global Enbrel Consumption and Growth Rate (2017-2022)
-
Figure Global Lantus Consumption and Growth Rate (2017-2022)
-
Figure Global Avastin Consumption and Growth Rate (2017-2022)
-
Figure Global Herceptin Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Inflammation Consumption and Growth Rate (2017-2022)
-
Figure Global Auto-Immune Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Blood Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Biologic Drugs Consumption by Country (2017-2022)
-
Table North America Biologic Drugs Consumption by Country (2017-2022)
-
Figure United States Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Canada Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Mexico Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Biologic Drugs Consumption by Country (2017-2022)
-
Figure Germany Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure UK Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Spain Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Belgium Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure France Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Italy Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Denmark Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Finland Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Norway Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Sweden Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Poland Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Russia Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Turkey Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Table APAC Biologic Drugs Consumption by Country (2017-2022)
-
Figure China Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Thailand Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Singapore Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Philippines Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Table South America Biologic Drugs Consumption by Country (2017-2022)
-
Figure Brazil Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Colombia Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Chile Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Argentina Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Peru Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Table GCC Biologic Drugs Consumption by Country (2017-2022)
-
Figure Bahrain Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Oman Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Qatar Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Table Africa Biologic Drugs Consumption by Country (2017-2022)
-
Figure Nigeria Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Africa Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Egypt Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Algeria Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Table Oceania Biologic Drugs Consumption by Country (2017-2022)
-
Figure Australia Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Biologic Drugs Consumption and Growth Rate (2017-2022)
-
Table Sanofi Company Details
-
Table Sanofi Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Biologic Drugs Main Business and Markets Served
-
Table Sanofi Biologic Drugs Product Portfolio
-
Table Johnson & Johnson Company Details
-
Table Johnson & Johnson Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Biologic Drugs Main Business and Markets Served
-
Table Johnson & Johnson Biologic Drugs Product Portfolio
-
Table Merck & Co Company Details
-
Table Merck & Co Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Biologic Drugs Main Business and Markets Served
-
Table Merck & Co Biologic Drugs Product Portfolio
-
Table Eli Lilly Company Details
-
Table Eli Lilly Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Biologic Drugs Main Business and Markets Served
-
Table Eli Lilly Biologic Drugs Product Portfolio
-
Table Abbott Laboratories Company Details
-
Table Abbott Laboratories Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Biologic Drugs Main Business and Markets Served
-
Table Abbott Laboratories Biologic Drugs Product Portfolio
-
Table Amgen Company Details
-
Table Amgen Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Biologic Drugs Main Business and Markets Served
-
Table Amgen Biologic Drugs Product Portfolio
-
Table Roche Company Details
-
Table Roche Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Biologic Drugs Main Business and Markets Served
-
Table Roche Biologic Drugs Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Biologic Drugs Main Business and Markets Served
-
Table Pfizer Biologic Drugs Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Biologic Drugs Main Business and Markets Served
-
Table Novartis Biologic Drugs Product Portfolio
-
Table Amgen Company Details
-
Table Amgen Biologic Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Biologic Drugs Main Business and Markets Served
-
Table Amgen Biologic Drugs Product Portfolio
-
Figure Global Humira Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Remicade Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Rituxan Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Enbrel Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lantus Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Avastin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Herceptin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Inflammation Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Auto-Immune Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Blood Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biologic Drugs Consumption Forecast by Country (2022-2028)
-
Table North America Biologic Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Biologic Drugs Consumption Forecast by Country (2022-2028)
-
Figure Germany Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Biologic Drugs Consumption Forecast by Country (2022-2028)
-
Figure China Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Biologic Drugs Consumption Forecast by Country (2022-2028)
-
Figure Brazil Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Biologic Drugs Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Biologic Drugs Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Biologic Drugs Consumption Forecast by Country (2022-2028)
-
Figure Australia Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Biologic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
